From betel nuts to Cobenfy: how an ancient recreational drug gave rise to a new class of schizophrenia medications

Justin Fortune Creeden, Siddharth N. Machiraju, Johansen B. Amin, Stephen M. Stahl

Open source

DOI
10.1017/s1092852925100424
Published
2025
Container
CNS Spectrums
Publisher
Cambridge University Press (CUP)
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1017/s1092852925100424,
  title = {From betel nuts to Cobenfy: how an ancient recreational drug gave rise to a new class of schizophrenia medications},
  author = {Justin Fortune Creeden and Siddharth N. Machiraju and Johansen B. Amin and Stephen M. Stahl},
  year = {2025},
  journal = {CNS Spectrums},
  doi = {10.1017/s1092852925100424},
  url = {https://doi.org/10.1017/s1092852925100424}
}

RIS

TY  - JOUR
TI  - From betel nuts to Cobenfy: how an ancient recreational drug gave rise to a new class of schizophrenia medications
AU  - Justin Fortune Creeden
AU  - Siddharth N. Machiraju
AU  - Johansen B. Amin
AU  - Stephen M. Stahl
PY  - 2025
JO  - CNS Spectrums
DO  - 10.1017/s1092852925100424
UR  - https://doi.org/10.1017/s1092852925100424
ER  - 

APA

Creeden, J. F., Machiraju, S. N., Amin, J. B., & Stahl, S. M. (2025). From betel nuts to Cobenfy: how an ancient recreational drug gave rise to a new class of schizophrenia medications. CNS Spectrums. https://doi.org/10.1017/s1092852925100424

Source records